EUVIMEDEUVIMED entdecken
Crossref

L26/P-545 Dose–response trends according to the number of intrauterine autologous platelet-rich plasma infusions in euploid frozen embryo transfer cycles with refractory thin endometrium

Y.E. Lee, E.A. Park, S.N. Hwang, M. Kang, J.I. Baek, J.Y. Lee, S. Sung, H.W. An, J. Park, S.H. Oh, K.A. Lee, E.H. Jo und 3 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y.E. Lee und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Is the number of intrauterine autologous platelet-rich plasma infusions associated with pregnancy outcomes in euploid frozen embryo transfer cycles with refractory thin endometrium? Summary answer Although overall comparisons across groups were not statistically significant, increasing numbers of PRP infusions were associated with consistent dose-dependent trends toward improved pregnancy outcomes. What is known already Refractory thin endometrium is associated with reduced implantation and pregnancy rates and often leads to cancellation of embryo transfer cycles. Autologous PRP has been proposed as a regenerative therapy to enhance endometrial receptivity; however, evidence regarding optimal treatment frequency, particularly in euploid embryo transfer cycles, remains limited. Study design, size, duration This retrospective cohort study analyzed 367 euploid frozen blastocyst transfer cycles performed between January 2022 and December 2024 at CHA University Fertility Center Seoul Station. Participants/materials, setting, methods Women with refractory thin endometrium (<7 mm) and a history of repeated cancelled FET cycles were included. No PRP infusion (n = 43), one infusion (n = 53), or two to three infusions (n = 271). Autologous PRP was prepared under sterile conditions and infused intrauterinely during the proliferative phase. All transferred embryos were confirmed euploid using next-generation sequencing. Overall comparisons across PRP exposure levels were performed using the chi-squared test, and additional trend analysis was conducted to evaluate dose–response relationships. Main results and the role of chance Clinical pregnancy rates increased stepwise with higher PRP exposure (30.2%, 35.8%, and 46.1%), without statistical significance in the overall comparison (overall p = 0.080). Implantation rates showed a similar pattern (23.2%, 25.3%, and 33.3%; overall p = 0.143). Miscarriage rates were numerically lower in PRP-treated cycles compared with no PRP exposure (46.2% vs. 10.5–24.0%; overall p = 0.069). Despite non-significant overall comparisons, trend analysis demonstrated consistent dose-dependent improvements in clinical pregnancy and implantation outcomes. Limitations, reasons for caution The retrospective design, unequal group sizes, and limited statistical power preclude causal inference. Wider implications of the findings In euploid FET cycles, increasing exposure to intrauterine autologous PRP was associated with consistent dose-dependent trends toward improved pregnancy outcomes, supporting further prospective investigation. Overall comparisons across PRP exposure levels were performed using the chi-squared test, and additional trend analysis was conducted to evaluate dose–response relationships. Trial registration number No

Zitieren

APA

Lee, Y., Park, E., Hwang, S., Kang, M., Baek, J., Lee, J., Sung, S., An, H., Park, J., Oh, S., Lee, K., Jo, E., Kim, J., Kim, M., & Yoon, T. (2026). L26/P-545 Dose–response trends according to the number of intrauterine autologous platelet-rich plasma infusions in euploid frozen embryo transfer cycles with refractory thin endometrium. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.878

Vancouver

Lee Y, Park E, Hwang S, Kang M, Baek J, Lee J, et al. L26/P-545 Dose–response trends according to the number of intrauterine autologous platelet-rich plasma infusions in euploid frozen embryo transfer cycles with refractory thin endometrium. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.878

BibTeX
@article{Lee2026,
  author = {Lee, Y.E. and Park, E.A. and Hwang, S.N. and Kang, M. and Baek, J.I. and Lee, J.Y. and Sung, S. and An, H.W. and Park, J. and Oh, S.H. and Lee, K.A. and Jo, E.H. and Kim, J.H. and Kim, M.J. and Yoon, T.K.},
  title = {L26/P-545 Dose–response trends according to the number of intrauterine autologous platelet-rich plasma infusions in euploid frozen embryo transfer cycles with refractory thin endometrium},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.878}
}
Kostenlos starten →